MTOR and neoplasm: Another case study reported GBM organoids established from a patient recurrent GBM with PTEN mutation and mTOR hyperactivation displayed sensitivity for the mTOR inhibitor everolimus, which was then given to the patient and led to a significant reduction of the tumor size [61].